PostDoc

Molecular pharmacologist and licensed pharmacist specializing in GPCR and second messenger pharmacology, translational immunopharmacology. PhD in Molecular Pharmacology from ETH Zurich, with expertise in in vivo transgenic models of cardiovascular and neurodegenerative disease and FRET-based biosensor development. Currently Postdoctoral Researcher in the Molecular Targets Group, Department of Pharmaceutical Sciences, University of Vienna, focusing on GPCR target identification and validation, biosensor-based cellular pharmacology, and the pharmacological characterization of natural compounds as modulators of immune cell-specific receptors (TGR5, GPR84, RORγ) and enzymes (PDE4). Research interests: GPCR signaling in immune cells, compartmentalized and biased GPCR signaling, and the identification of novel pharmacological targets in inflammatory and autoimmune diseases.